[1]Patent:CN105254613,2016,A.Locationinpatent:Paragraph0141;0142;0143
[1]Yu,Mingfeng;Long,Yi;Yang,Yuchao;Li,Manjun;Teo,Theodosia;Noll,Benjamin;Philip,Stephen;Wang,Shudong[EuropeanJournalofMedicinalChemistry,2021,vol.218]
1256359-09-7
1310405-33-4
1313738-64-5
885698-95-3
885698-94-2
1204580-79-9
123855-55-0 | 4-Nitrophenyl 2-(furfurylsulfinyl)acetic acid | AA000L3Q | MFCD08063946
1240390-28-6 | 2,4-Dichloropyrimidine-5-carboxylic acid amide | AA000LCZ | MFCD16658133
124257-62-1 | (1-Benzylpiperidin-3-yl)methanamine | AA000LOZ | MFCD05668290
1245210-84-7 | 2-Methyl-1,7-naphthyridin-4-amine | AA000M2N | MFCD18711470
1246086-78-1 | 2-Pyridinecarboxamide, N-[3-chloro-4-[[(2-chlorophenyl)amino]sulfonyl]phenyl]- | AA000MDO | MFCD22378484
124750-53-4 | 1H-Tetrazole, 5-(4'-methyl[1,1'-biphenyl]-2-yl)-1-(triphenylmethyl)- | AA000MN4 | MFCD00665220
1250993-54-4 | Cis-5-boc-octahydropyrrolo[3,2-c]pyridine | AA000N2F | MFCD12198716
125299-79-8 | Tetra(3,5-dibromo-4-hydroxyphenyl)porphyrin | AA000ND6 | MFCD21608645
1255098-88-4 | Oxazole-2-carboxylic acid sodium salt | AA000NOX | MFCD17926331
1256345-59-1 | 4-bromo-3-methoxyphenylboronic acid | AA000NXE | MFCD16036103